meglumine has been researched along with Brain Neoplasms in 119 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (3.36) | 18.7374 |
1990's | 34 (28.57) | 18.2507 |
2000's | 28 (23.53) | 29.6817 |
2010's | 48 (40.34) | 24.3611 |
2020's | 5 (4.20) | 2.80 |
Authors | Studies |
---|---|
Black, KL; Ding, H; Galstyan, A; Grodzinski, ZB; Holler, E; Israel, LL; Ljubimova, JY; Patil, R; Shatalova, ES; Wagner, S | 1 |
Jang, S; Kang, H | 1 |
Bessou, P; Chateil, JF; Crombé, A; Gaillard, AL; Havez, M; Jecko, V; Pédespan, JM; Van Gils, J | 1 |
Aizenberg, M; Appiah, AK; Kazmi, SAJ; Shonka, N; White, ML; Yu, F; Zhang, Y | 1 |
Barr, RG; Chang, EY; Colosimo, C; DeLano, MC; Kirchin, MA; Lichtenstein, RJ; Lin, DDM; Pirovano, G; Spampinato, MV; Vymazal, J; Wen, Z | 1 |
Cao, D; Lin, Y; She, D; Wang, X; Xiao, Z; Xing, Z; Yang, X; Zheng, Y | 1 |
Cottier, JP; Gaillot, K; Marechal, B; Morel, B; Rochetams, BB; Sembely-Taveau, C; Sirinelli, D | 1 |
Agati, R; Bacci, A; Casolino, D; Catanese, A; Cirillo, L; Malacario, F; Toni, F; Zenesini, C | 1 |
Bag, A; Elizondo-Riojas, G; Escobar, W; Fiebach, JB; Fink, JR; Hao, J; Herskovits, E; Kim, SJ; Maravilla, KR; Pitrou, C; Roberts, DR; San-Juan, D; Tsiouris, AJ | 1 |
Absil, J; Lemort, M; Manto, M; Metens, T; Perrotta, G | 1 |
Batouli, A; Gholamrezanezhad, A; Kanal, E; Spearman, M | 1 |
Ahlawat, S; Beniwal, M; Gupta, PK; Gupta, RK; Patir, R; Sahoo, P; Saini, J; Santosh, V; Singh, A; Thennarasu, K | 1 |
Holdsworth, SJ; Macpherson, SJ; Wintermark, M; Yeom, KW; Zaharchuk, G | 1 |
Bruce, RJ; Diamond, CA; Kinner, S; Rebsamen, SL; Reeder, SB; Rowley, HA; Schubert, TB | 1 |
Bowden, SG; Bruce, JN; Canoll, P; Chow, DS; Englander, ZK; Grinband, J; Horenstein, CI; Lignelli, A; Otten, ML | 1 |
Doshi, AH; Erly, WK; Germano, IM; Knitter, JR; Lemole, GM; Nael, K; Stea, BD | 1 |
Hedderich, D; Kirschke, JS; Kluge, A; Preibisch, C; Pyka, T; Wiestler, B; Zimmer, C | 1 |
Casseri, T; Cerase, A; Galluzzi, P; Guglielmucci, D; Hadjistilianou, T; Toti, P | 1 |
Federau, C; Gallichan, D; Glessgen, C; Hainc, N; Moor, M | 1 |
Bobacka, J; Ek, P; Frantzén, J; Gardberg, M; Kiviniemi, A; Minn, H | 1 |
Weiß, M | 1 |
Ducot, B; Ducreux, D; Lacroix, C; Saliou, G; Vandendries, C | 1 |
Bandirali, M; Di Leo, G; Khouri Chalouhi, K; Papini, GDE; Sardanelli, F; Sconfienza, LM | 1 |
Bazille, G; Jeung, MY; Ohana, M; Roy, C | 1 |
Akbari, H; Bilello, M; Da, X; Davatzikos, C; Macyszyn, L; O'Rourke, DM; Verma, R; Wolf, RL | 1 |
Juras, V; Kronnerwetter, C; Ladd, ME; Nemec, S; Noebauer-Huhmann, IM; Prayer, D; Szomolanyi, P; Trattnig, S; Weber, M; Widhalm, G | 1 |
Bendszus, M; Bonekamp, D; Deike, K; Heiland, S; Radbruch, A; Wick, W; Wiestler, B | 1 |
Cardinal, JS; Ho, CY; Kamer, AP; Kralik, SF | 1 |
Babbel, R; Baima, JJ; Bonafé, A; Buhk, JH; Bültmann, E; Colosimo, C; Herman, M; Huang, RY; Kirchin, MA; Lui, S; Maravilla, KR; Mechl, M; Pirovano, G; Shen, N; Smith, MP; Spampinato, MV; Spinazzi, A; Vaneckova, M; Weichet, J; Wippold, FJ; Žižka, J | 1 |
Engelholm, SA; Larsson, HB; Law, I; Lundemann, M; Møller, S; Poulsen, HS | 1 |
Katz, JS; Knisely, JP; Kushnirsky, M; Nguyen, V; Rosen, L; Schulder, M; Steinklein, J; Warshall, C | 1 |
Bendszus, M; Bonekamp, D; Burth, S; Heiland, S; Kickingereder, P; Radbruch, A; Schlemmer, HP; Wick, A; Wick, W | 1 |
Aydın, Ö; Büyükkaya, R; Hakyemez, B | 1 |
Bendszus, M; Bonekamp, D; Burth, S; Eidel, O; Götz, M; Kickingereder, P; Maier-Hein, KH; Radbruch, A; Schlemmer, HP; Wick, A; Wick, W | 1 |
Bozzetti, F; Crisi, G; Erb, G; Filice, S | 1 |
Artzi, M; Bashat, DB; Kiryati, N; Liberman, G; Nadav, G | 1 |
Choi, CG; Kim, C; Kim, HS; Kim, JH; Kim, SJ; Shim, WH | 1 |
Bonnin, J; Gener, M; Ho, CY; Kralik, SF | 1 |
Bastianello, S; Bowen, BC; Colosimo, C; Gallucci, M; Gao, PY; Hassell, D; Kuhn, MJ; Maldjian, JA; Rowley, HA; Ruscalleda, J; Schmalfuss, IM; Scialfa, G; Wippold, FJ | 1 |
Cotton, F; Hermier, M | 1 |
Bastianello, S; Gustafsson, L; Maldjian, JA; Rowley, HA; Rumboldt, Z; Ruscalleda, J; Steinberg, F | 1 |
Attenberger, UI; Baumann, S; Birkemeier, K; Jackson, CB; Michaely, HJ; Reiser, MF; Runge, VM; Schoenberg, SO; Wintersperger, BJ | 1 |
Huang, B; Liang, CH; Liu, HJ; Wang, GY; Zhang, SX | 1 |
Attenberger, UI; Jackson, CB; Michaely, HJ; Morelli, JN; Runge, VM; Williams, J | 1 |
Anzalone, N | 1 |
Kramer, H; Loynachan, AT; Naul, LG; Reiser, MF; Runge, VM; Wintersperger, BJ | 1 |
Essig, M; Giesel, FL; Mehndiratta, A | 1 |
Botnar, RM; Brinker, G; Ernestus, RI; Jacobs, JE; Kleimann, JF; Lackner, KJ; Loehr, M; Möller-Hartmann, W; Poggenborg, J; Spuentrup, E; Wiethoff, AJ | 1 |
Anzalone, N; Carriero, A; Cirillo, M; Colosimo, C; Cova, MA; Cristaudo, C; Floris, R; Gatti, S; Longo, M; Scarabino, T; Scotti, G; Tartaro, A; Venturi, C; Voth, M; Zimatore, D | 1 |
Abud, L; Capelle, L; Chiras, J; Costalat, R; Guillevin, R; Habas, C; Hoang-Xuan, K; Menuel, C; Vallée, JN | 1 |
Chen, W; Feng, D; Luo, X; Qi, J; Wang, L; Xia, L; Zhu, W | 1 |
Ma, L; Wang, QJ; Wang, Y; Xiao, H; Xu, X | 1 |
Anzalone, N; Bastianello, S; Citterio, A; Colosimo, C; Goyal, M; Herman, M; Mechl, M; Paraniak-Gieszczyk, B; Pasowicz, M; Ruscalleda, J; Schneider, G; Seidl, Z; Vymazal, J; Yemen, B; Yeung, R | 1 |
De Keyzer, F; De Vleeschouwer, S; Himmelreich, U; Peeters, RR; Sijbers, J; Sunaert, S; Van Calenbergh, F; Van Cauter, S; Van Gool, SW; Van Hecke, W; Veraart, J | 1 |
Desché, P | 1 |
Colosimo, C; De Waure, C; Di Lella, GM; Gaudino, S; Gualano, MR; Lo Russo, VS; Piludu, F; Quaglio, FR; Russo, R | 1 |
Chen, X; Li, CX; Li, ZL; Song, B; Sun, JY; Tang, HH; Xia, CC | 1 |
Essig, M; Hartman, M; Jansen, O; Kirchin, MA; Knopp, MV; Lodemann, KP; Moeller, A; Runge, VM; Seeberg, AH | 1 |
Barreau, X; Colosimo, C; Gérardin, E; Guézénoc, F; Kirchin, MA; Knopp, MV; Lodemann, KP | 1 |
Jansen, O | 1 |
Essig, M | 1 |
Christophe, C; Colosimo, C; Demaerel, P; Högström, B; Kirchin, MA; Pirovano, G; Shen, N; Spinazzi, A; Tortori-Donati, P; Van Buchem, M | 1 |
Baumann, SS; Biswas, J; Herborn, CU; Jackson, CB; Patel, T; Runge, VM; Wintersperger, BJ | 1 |
Cotton, F | 1 |
Anzalone, N; Bowen, BC; Essig, M; Gustafsson, L; Knopp, MV; Kuhn, MJ; Maldjian, JA; Maravilla, KR; Picozzi, P; Runge, VM; Schmalfuss, IM; Wippold, FJ; Wolansky, LJ | 1 |
Callot, V; Cozzone, P; Figarella-Branger, D; Galanaud, D; Lefur, Y; Metellus, P; Nicoli, F | 1 |
Kirchin, MA; Picozzi, P | 1 |
Friedrich, K; Hoeftberger, R; Karanikas, G; Knosp, E; Noebauer-Huhmann, IM; Pinker, K; Stadlbauer, A; Stavrou, I; Szomolanyi, P; Trattnig, S; Weber, M | 1 |
Grabner, G; Hoeftberger, R; Knosp, E; Noebauer-Huhmann, IM; Pinker, K; Stadlbauer, A; Stavrou, I; Szomolanyi, P; Trattnig, S; Weber, M | 1 |
Bozzao, A; Fantozzi, LM; Fasoli, F; Ferrante, L; Ferrante, M; Romano, A | 1 |
Karttunen, A; Koivukangas, J; Vaara, T; Yrjänä, SK | 1 |
Hans, FJ; Krings, T; Reinacher, P; Reinges, MH; Simon, VA | 1 |
Brachmann, J; Dietrich, J | 1 |
Kangasniemi, P; Majurin, ML; Raininko, R; Virtama, P | 1 |
Eder, HG; Leber, KA; Pendl, G | 1 |
Kurki, T; Niemi, P; Valtonen, S | 1 |
Haughton, VM; Lindsey, RO; Prost, R; Yetkin, FZ | 1 |
Enzmann, DR; Haros, SP; Mehta, RC; Pike, GB | 1 |
Raaphorst, GP; Saunders, JK; Smith, IC; Sutherland, GR; Wilkins, DE | 1 |
Nagashima, T; Tada, Y; Takada, M; Tamaki, N | 1 |
Cha, SH; Chang, KH; Han, MC; Han, MH; Kim, HD; Ra, DG | 1 |
Chess, MA; Meyers, SP; Tarr, RW; Wildenhain, S | 1 |
Higano, S; Ikeda, H; Ishii, K; Matsumoto, K; Sakamoto, K; Takahashi, S | 1 |
Kenney, J; Krueck, WG; Maravilla, KR; Schmiedl, UP; Spence, AM; Starr, FL | 1 |
Friedman, H; Schumacher, DJ; Tien, RD | 1 |
Baert, AL; Casselman, J; Defloor, E; Delanote, G; Demaerel, P; Dewulf, P; Wilms, G | 1 |
Bydder, GM; De Coene, B; Hajnal, JV; Pennock, JM | 1 |
Di Chiro, G; Dwyer, AJ; Fulham, MJ; Melisi, JW; Nishimiya, J | 1 |
Hayashi, N; Ishii, Y; Itoh, S; Iwasaki, T; Kimura, H; Kubota, T; Maeda, M; Yamamoto, K | 1 |
Brant-Zawadzki, M; Jensen, MC | 1 |
Barkley, GL; Mehta, BA; Sanders, WP; Silbergleit, R; Spickler, EM | 1 |
Brix, G; Debus, J; Engenhart, R; Hess, T; Knopp, MV; Rempp, K; van Kaick, G; Wannenmacher, M; Wenz, F | 1 |
Brotchi, J; Camby, I; Danguy, A; Kiss, R; Martinez, J; Pasteels, JL; Salmon, I | 1 |
De Silva, M; McHugh, K; North, KN; Van Es, S | 1 |
Elster, AD; Hamilton, CA; Mathews, VP; Moran, PR; Ulmer, JL | 1 |
Bruening, R; Cher, L; Harsh, GR; Hochberg, FH; Kwong, KK; Niemi, PT; Rosen, BR; Vevea, MJ; Weisskoff, RM | 1 |
Aronen, HJ; Jääskeläinen, J; Peltonen, TK; Ruhala, MT; Sepponen, R; Sipilä, LM; Tanttu, JI | 1 |
Cohen, JK; Eldevik, OP; Quint, DJ | 1 |
Crawley, AP; Gaul, HP; Wallace, CJ | 1 |
Amano, M; Amano, Y; Kumazaki, T | 1 |
Castelli, PM; Cavagna, FM; Daprà, M; Imperatori, LG; Jenkins, BG; Lorusso, V; Maggioni, F | 1 |
Bryce, R; Etienne, MC; Ferrero, JM; Fischel, JL; Formento, P; Ilc, K; Milano, G | 1 |
Kirchin, MA; La Noce, A; Pirovano, G; Ruscalleda, J; Spinazzi, A | 1 |
Brochard, T; Charvet, AM; Collomb, A; Corde, S; Elleaume, H; Estève, F; Fiedler, S; Le Bas, JF; Le Duc, G | 1 |
Aube, C; Burtin, P; Caron-Poitreau, C; Haba, D; Pasco Papon, A; Tanguy, JY | 1 |
Armstrong, MR; Barr, RG; Berger, BL; Czervionke, LF; Gonzalez, CF; Halford, HH; Kanal, E; Kuhn, MJ; Levin, JM; Low, RN; Runge, VM; Tanenbaum, LN; Wang, AM; Wong, W; Yuh, WT; Zoarski, GH | 1 |
Colosimo, C; Kirchin, MA; Korves, M; La Ferla, R; Pianezzola, P; Ruscalleda, J; Wool, C | 1 |
Colosimo, C; Kirchin, MA; Korves, M; La Noce, A; Pirovano, G; Ruscalleda, J; Salerio, I; Schneider, G; Spinazzi, A | 1 |
Essig, M; Hartmann, M; Jansen, O; Knopp, MV; Lodemann, KP; Runge, VM; Seeberg, A | 1 |
Matsumura, A; Nose, T; Shimojo, N; Yamamoto, T; Yoshida, F; Zhang, T | 1 |
Balériaux, D; Bohndorf, K; Bongartz, G; Bourne, MW; Cherryman, GR; Colosimo, C; Kirchin, MA; Korves, M; La Noce, A; Parizel, PM; Pirovano, G; Reiser, M; Ruscalleda, J; Salerio, I; Sartor, K; Schneider, G; Spinazzi, A; van Buchem, MA | 1 |
Donovan, M; Parker, JR; Runge, VM | 1 |
Børseth, A; Myhr, G; Rinck, PA | 1 |
Mirowitz, SA | 1 |
Altman, NR; Bilaniuk, LT; Braffman, BH; Brody, BA; Naidich, TP; Post, MJ; Quencer, RM; Zimmerman, RA | 1 |
Crain, MR; Ehrhardt, JC; Engelken, JD; Fisher, DJ; Greene, GM; Ryals, TJ; Sato, Y; Yuh, WT | 1 |
Agnoli, AL; Herrmann, S | 1 |
Avrahami, E; Cohn, DF; Weiss-Peretz, J | 1 |
Bielke, G; Grigat, M; Higer, HP; Jungke, M; Just, M; Kunze, S; Meindl, S; Pedrosa, P; Voth, D | 1 |
7 review(s) available for meglumine and Brain Neoplasms
Article | Year |
---|---|
Diffusion, Perfusion, and Histopathologic Characteristics of Desmoplastic Infantile Ganglioglioma.
Topics: Brain Neoplasms; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Ganglioglioma; Humans; Infant; Male; Meglumine; Organometallic Compounds | 2016 |
The advantage of high relaxivity contrast agents in brain perfusion.
Topics: Blood-Brain Barrier; Brain Abscess; Brain Diseases; Brain Injuries; Brain Neoplasms; Cerebrovascular Circulation; Cerebrovascular Disorders; Contrast Media; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2006 |
High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review.
Topics: Brain; Brain Mapping; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Hemodynamics; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Meglumine; Models, Neurological; Neovascularization, Pathologic; Organometallic Compounds; Stroke | 2010 |
MultiHance in brain tumor imaging.
Topics: Brain; Brain Neoplasms; Contrast Media; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Meglumine; Organometallic Compounds | 2004 |
MultiHance in brain perfusion.
Topics: Brain; Brain Neoplasms; Contrast Media; Echo-Planar Imaging; Humans; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Time Factors | 2004 |
Improving lesion detection and visualization: implications for neurosurgical planning and follow-up.
Topics: Brain Neoplasms; Contrast Media; Decision Making, Computer-Assisted; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2007 |
MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
Topics: Adolescent; Adult; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Tuberous Sclerosis | 1992 |
23 trial(s) available for meglumine and Brain Neoplasms
Article | Year |
---|---|
Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.
Topics: Brain; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2021 |
Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Signal-To-Noise Ratio; Young Adult | 2017 |
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Cross-Over Studies; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2015 |
Effectiveness of a high relaxivity contrast agent administered at half dose in dynamic susceptibility contrast MRI of brain gliomas.
Topics: Adult; Brain Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Sensitivity and Specificity; Young Adult | 2008 |
Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Statistics, Nonparametric; United States | 2009 |
Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Topics: Brain; Brain Neoplasms; Contrast Media; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method | 2013 |
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Czech Republic; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2012 |
Re: Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Topics: Body Weight; Brain Neoplasms; Contrast Media; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2012 |
Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2004 |
A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.
Topics: Aged; Brain Neoplasms; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Glioma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Sensitivity and Specificity | 2004 |
Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Double-Blind Method; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Infant; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies; Safety; Spinal Neoplasms | 2005 |
Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Contrast Media; Cross-Over Studies; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results | 2007 |
Effect of dose and field strength on enhancement with paramagnetic contrast media.
Topics: Brain Neoplasms; Cavernous Sinus; Choroid Plexus; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Image Enhancement; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Maxillary Sinus; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms | 1994 |
MultiHance in the assessment of intracranial tumors: results of phase II clinical studies.
Topics: Adult; Aged; Brain; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Echo-Planar Imaging; Female; Gadolinium; Humans; Injections, Intravenous; Male; Meglumine; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Pilot Projects; Reproducibility of Results; Safety | 1999 |
A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
Topics: Brain Neoplasms; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2001 |
Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage.
Topics: Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2001 |
Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation.
Topics: Brain; Brain Neoplasms; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2001 |
[Comparison of contrast behavior of gadobenate-dimeglumine and Gd-DTPA in intra-axial brain tumors. A double-blind randomized intraindividual cross-over study].
Topics: Brain; Brain Neoplasms; Contrast Media; Cross-Over Studies; Double-Blind Method; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Meglumine; Observer Variation; Organometallic Compounds | 2001 |
Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine.
Topics: Brain Neoplasms; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Safety | 2002 |
Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain.
Topics: Brain Neoplasms; Chelating Agents; Contrast Media; Corpus Callosum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2002 |
Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Neoplasms; Contrast Media; Double-Blind Method; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1992 |
MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol.
Topics: Adult; Agar; Aged; Brain Neoplasms; Contrast Media; Drug Combinations; Drug Evaluation; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Models, Structural; Organometallic Compounds; Pentetic Acid; Single-Blind Method | 1991 |
89 other study(ies) available for meglumine and Brain Neoplasms
Article | Year |
---|---|
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Female; Glioblastoma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Mice, Nude; Nanostructures; Organometallic Compounds; Xenograft Model Antitumor Assays | 2020 |
The diagnostic value of postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasm at 3T.
Topics: Aged; Aged, 80 and over; Brain; Brain Neoplasms; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results | 2021 |
Magnetic resonance imaging diagnosis of subependymal giant cell astrocytomas in follow-up of children with tuberous sclerosis complex: should we always use contrast enhancement?
Topics: Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tuberous Sclerosis | 2020 |
Evaluating survival in subjects with astrocytic brain tumors by dynamic susceptibility-weighted perfusion MR imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Mapping; Brain Neoplasms; Databases, Factual; Humans; Kaplan-Meier Estimate; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Temozolomide; Young Adult | 2021 |
IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.
Topics: Adult; Biomarkers, Tumor; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Magnetic Resonance Imaging; Male; Meglumine; Mutation; Neoplasm Grading; Oligodendroglioma; Organometallic Compounds; Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies | 2017 |
T1-weighted dynamic contrast-enhanced brain magnetic resonance imaging: A preliminary study with low infusion rate in pediatric patients.
Topics: Brain Neoplasms; Child; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Male; Meglumine; Neoplasm Grading; Neuroimaging; Organometallic Compounds; Prospective Studies; Stroke | 2017 |
Application of intravoxel incoherent motion (IVIM) magnetic resonance imaging in the evaluation of primitive brain tumours.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Motion; Neoplasm Grading; Organometallic Compounds | 2018 |
Absence of clinical cerebellar syndrome after serial injections of more than 20 doses of gadoterate, a macrocyclic GBCA: a monocenter retrospective study.
Topics: Adult; Brain Neoplasms; Cerebellum; Child; Contrast Media; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Tissue Distribution | 2017 |
T1-weighted parenchyma attenuated inversion recovery: A novel sequence that improves contrast ratio of enhancing brain lesions.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Signal-To-Noise Ratio; Young Adult | 2018 |
Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Contrast Media; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Retrospective Studies | 2018 |
Clinical Evaluation of Silent T1-Weighted MRI and Silent MR Angiography of the Brain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2018 |
Deep Brain Nuclei T1 Shortening after Gadobenate Dimeglumine in Children: Influence of Radiation and Chemotherapy.
Topics: Adolescent; Brain; Brain Neoplasms; Chemoradiotherapy; Child; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies | 2018 |
Extent of BOLD Vascular Dysregulation Is Greater in Diffuse Gliomas without Isocitrate Dehydrogenase 1 R132H Mutation.
Topics: Biomarkers, Tumor; Brain Neoplasms; Contrast Media; Echo-Planar Imaging; Female; Glioma; Humans; Image Enhancement; Isocitrate Dehydrogenase; Male; Meglumine; Middle Aged; Mutation; Organometallic Compounds; Retrospective Studies | 2018 |
Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation.
Topics: Aged; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiosurgery | 2018 |
Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
Topics: Algorithms; Brain Neoplasms; Cerebral Blood Volume; Contrast Media; Female; Gadolinium DTPA; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results | 2019 |
Conventional, diffusion, and permeability MR findings in ocular medulloepithelioma.
Topics: Brain Neoplasms; Child; Child, Preschool; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Infant; Infant, Newborn; Magnetic Resonance Imaging; Male; Meglumine; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Organometallic Compounds; Retrospective Studies | 2018 |
Evaluation of 3D fat-navigator based retrospective motion correction in the clinical setting of patients with brain tumors.
Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Artifacts; Brain Neoplasms; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Motion; Organometallic Compounds; Retrospective Studies | 2019 |
Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
Topics: Brain; Brain Neoplasms; Contrast Media; Female; Gadolinium DTPA; Glioma; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2019 |
[Non-ionic contrast agent gadobutrol preference clarified].
Topics: Brain; Brain Neoplasms; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 2013 |
Statistical analysis of multi-b factor diffusion weighted images can help distinguish between vasogenic and tumor-infiltrated edema.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Brain Edema; Brain Neoplasms; Contrast Media; Data Interpretation, Statistical; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Sensitivity and Specificity | 2014 |
Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI.
Topics: Brain Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2014 |
Cerebral staging of lung cancer: is one single contrast-enhanced T1-weighted three-dimensional gradient-echo sequence sufficient?
Topics: Aged; Asymptomatic Diseases; Brain Neoplasms; Carcinoma; Contrast Media; Echo-Planar Imaging; Female; Humans; Imaging, Three-Dimensional; Lung Neoplasms; Male; Meglumine; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2014 |
Pattern analysis of dynamic susceptibility contrast-enhanced MR imaging demonstrates peritumoral tissue heterogeneity.
Topics: Brain Neoplasms; Contrast Media; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Neoplasm Recurrence, Local; Organometallic Compounds; Pattern Recognition, Automated; Principal Component Analysis; Retrospective Studies | 2014 |
Brain tumours at 7T MRI compared to 3T--contrast effect after half and full standard contrast agent dose: initial results.
Topics: Adult; Aged; Artifacts; Brain Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies | 2015 |
Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Computer Simulation; Contrast Media; Female; Germany; Glioblastoma; Humans; Image Enhancement; Imaging, Three-Dimensional; Incidence; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Models, Biological; Organometallic Compounds; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Analysis | 2015 |
Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors.
Topics: Adolescent; Blood Volume; Blood Volume Determination; Brain Neoplasms; Cerebrovascular Circulation; Child; Child, Preschool; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Infant; Magnetic Resonance Angiography; Male; Meglumine; Observer Variation; Organometallic Compounds; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity | 2015 |
Early changes in perfusion of glioblastoma during radio- and chemotherapy evaluated by T1-dynamic contrast enhanced magnetic resonance imaging.
Topics: Brain Neoplasms; Contrast Media; Glioblastoma; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies; Radiotherapy, Intensity-Modulated | 2015 |
Time-delayed contrast-enhanced MRI improves detection of brain metastases and apparent treatment volumes.
Topics: Adult; Brain Neoplasms; Contrast Media; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Meglumine; Observer Variation; Organometallic Compounds; Radiosurgery; Treatment Outcome | 2016 |
MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Female; Glioblastoma; Hemodynamics; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Organometallic Compounds; Prognosis; Retrospective Studies; Survival Rate | 2016 |
Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Neovascularization, Pathologic; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Young Adult | 2017 |
Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models.
Topics: Brain Neoplasms; Contrast Media; Female; Germany; Glioblastoma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Survival Rate; Tumor Burden | 2016 |
Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.
Topics: Blood Flow Velocity; Brain Neoplasms; Cerebrovascular Circulation; Computer Simulation; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Male; Meglumine; Models, Cardiovascular; Models, Neurological; Neovascularization, Pathologic; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Recurrent Glioblastoma: Combination of High Cerebral Blood Flow with MGMT Promoter Methylation Is Associated with Benefit from Low-Dose Temozolomide Rechallenge at First Recurrence.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Blood Volume; Brain Neoplasms; Cerebrovascular Circulation; Combined Modality Therapy; Contrast Media; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; O(6)-Methylguanine-DNA Methyltransferase; Organometallic Compounds; Polymerase Chain Reaction; Retrospective Studies; Temozolomide; Treatment Outcome | 2017 |
Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Topics: Animals; Brain Neoplasms; Chelating Agents; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Gadolinium DTPA; Humans; Image Enhancement; Meglumine; Organometallic Compounds; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Topics: Aged; Brain Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Statistics, Nonparametric | 2010 |
Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chelating Agents; Disease Models, Animal; Gadolinium DTPA; Glioma; Humans; Ions; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats; Rats, Inbred F344 | 2010 |
Comparative studies of different gadolinium agents in brain tumors: differences between gadolinium chelates and their possible influence on imaging features.
Topics: Brain Neoplasms; Clinical Trials as Topic; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Radiography | 2010 |
Brain MRI with single-dose (0.1 mmol/kg) Gadobutrol at 1.5 T and 3 T: comparison with 0.15 mmol/kg Gadoterate meglumine.
Topics: Animals; Brain; Brain Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Female; Glioma; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Rats; Rats, Inbred F344; Reproducibility of Results; Sensitivity and Specificity | 2010 |
High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T.
Topics: Adult; Aged; Brain Neoplasms; Carotid-Cavernous Sinus Fistula; Cerebral Arteries; Cerebral Veins; Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Intracranial Arteriovenous Malformations; Magnetic Resonance Angiography; Male; Meglumine; Middle Aged; Organometallic Compounds; Sensitivity and Specificity; Sinus Thrombosis, Intracranial; Video Recording | 2010 |
Proton MR spectroscopy in predicting the increase of perfusion MR imaging for WHO grade II gliomas.
Topics: Adult; Brain Neoplasms; Contrast Media; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Prospective Studies; Protons; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric; World Health Organization | 2012 |
Multicontrast single-slab 3D MRI to detect cerebral metastasis.
Topics: Adult; Aged; Area Under Curve; Brain Neoplasms; Chi-Square Distribution; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; ROC Curve; Sensitivity and Specificity | 2012 |
[Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2011 |
Gliomas: diffusion kurtosis MR imaging in grading.
Topics: Adult; Aged; Anisotropy; Area Under Curve; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Glioma; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Meglumine; Middle Aged; Neoplasm Grading; Organometallic Compounds; Prospective Studies; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric | 2012 |
Magnetic resonance imaging of solitary brain metastases: main findings of nonmorphological sequences.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Aspartic Acid; Blood Volume; Brain Neoplasms; Child; Choline; Contrast Media; Creatine; Diffusion Magnetic Resonance Imaging; Female; Humans; Lipids; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Organometallic Compounds | 2012 |
[Comparison of the efficacy of gadobutrol and multihance in contrast-enhanced MRI for diagnosis of brain metastasis in lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Contrast Media; Female; Humans; Image Enhancement; Lung Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2012 |
The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
Topics: Animals; Brain Neoplasms; Contrast Media; Female; Gadolinium DTPA; Glioma; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Random Allocation; Rats; Rats, Inbred F344 | 2006 |
Diffusion-perfusion in intra-axial brain tumors with high relaxivity contrast agents.
Topics: Adolescent; Aged; Biopsy; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds | 2006 |
Correlations between MR and endothelial hyperplasia in low-grade gliomas.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Endothelium, Vascular; Female; Glioma; Humans; Hyperplasia; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Statistics, Nonparametric | 2007 |
High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.
Topics: Adult; Aged; Brain Neoplasms; Contrast Media; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2007 |
High-field, high-resolution, susceptibility-weighted magnetic resonance imaging: improved image quality by addition of contrast agent and higher field strength in patients with brain tumors.
Topics: Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Contrast Media; Efficiency; Ependymoma; Female; Glioblastoma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Oligodendroglioma; Organometallic Compounds; Plasmacytoma; Sensitivity and Specificity | 2008 |
Fiber density index, fractional anisotropy, adc and clinical motor findings in the white matter of patients with glioblastoma.
Topics: Adult; Aged; Anisotropy; Brain; Brain Mapping; Brain Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Functional Laterality; Glioblastoma; Humans; Image Enhancement; Male; Meglumine; Middle Aged; Nerve Fibers; Observer Variation; Organometallic Compounds; Paresis; Pyramidal Tracts; Reproducibility of Results | 2008 |
Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
Topics: Adult; Brain Neoplasms; Computer Simulation; Contrast Media; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Models, Theoretical; Organometallic Compounds | 2008 |
Dynamic 3-D contrast-enhanced angiography of cerebral tumours and vascular malformations.
Topics: Angiography, Digital Subtraction; Artifacts; Brain Neoplasms; Contrast Media; Humans; Imaging, Three-Dimensional; Intracranial Arteriovenous Malformations; Magnetic Resonance Angiography; Meglumine; Meningioma; Organometallic Compounds; Subtraction Technique | 2007 |
[Comparison of the results of computer tomography and dimer-X ventriculography in the diagnosis of infratentorial processes].
Topics: Brain Neoplasms; Brain Stem; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Cerebral Ventriculography; Contrast Media; Diagnosis, Differential; Humans; Iothalamic Acid; Meglumine; Sorbitol; Tomography, X-Ray Computed | 1983 |
Value of high contrast medium dose in brain CT.
Topics: Brain; Brain Diseases; Brain Neoplasms; Contrast Media; Diatrizoate Meglumine; Humans; Iodamide; Iodipamide; Meglumine; Tomography, X-Ray Computed | 1982 |
Localization of superficial cerebral lesions using a magnetic resonance imaging-guided localizer.
Topics: Brain Neoplasms; Cerebral Cortex; Contrast Media; Craniotomy; Drug Combinations; Gadolinium DTPA; Gliosarcoma; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Motor Cortex; Organometallic Compounds; Pentetic Acid; Somatosensory Cortex | 1995 |
MR of intracranial tumors: combined use of gadolinium and magnetization transfer.
Topics: Astrocytoma; Brain; Brain Edema; Brain Neoplasms; Contrast Media; Diagnostic Errors; Drug Combinations; Gadolinium DTPA; Glioblastoma; Humans; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Meglumine; Meningeal Neoplasms; Meningioma; Organometallic Compounds; Pentetic Acid | 1994 |
Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging.
Topics: Adult; Aged; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebral Infarction; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1995 |
Correlation between Gd-enhanced MR imaging and histopathology in treated and untreated 9L rat brain tumors.
Topics: Animals; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Meglumine; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 1995 |
Formation and resolution of brain edema associated with brain tumors. A comprehensive theoretical model and clinical analysis.
Topics: Blood-Brain Barrier; Brain Edema; Brain Neoplasms; Contrast Media; Convection; Diffusion; Drug Combinations; Gadolinium DTPA; Humans; Iopamidol; Magnetic Resonance Imaging; Meglumine; Meningeal Neoplasms; Meningioma; Models, Theoretical; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed; Water-Electrolyte Balance | 1994 |
Contrast enhancement of brain tumors at different MR field strengths: comparison of 0.5 T and 2.0 T.
Topics: Adolescent; Adult; Aged; Artifacts; Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Meningioma; Middle Aged; Neurilemmoma; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1994 |
Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
Topics: Adolescent; Adult; Arachnoid; Bone Neoplasms; Brain; Brain Neoplasms; Cerebral Ventricles; Child; Child, Preschool; Contrast Media; Drug Combinations; Dura Mater; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Infant; Magnetic Resonance Imaging; Male; Medulloblastoma; Meglumine; Neoplasm Recurrence, Local; Organometallic Compounds; Pentetic Acid; Pia Mater; Postoperative Care; Retrospective Studies | 1994 |
Germinoma originating in the basal ganglia and thalamus: MR and CT evaluation.
Topics: Adolescent; Atrophy; Basal Ganglia Diseases; Brain; Brain Neoplasms; Brain Stem; Calcinosis; Child; Contrast Media; Cysts; Drug Combinations; Gadolinium; Gadolinium DTPA; Germinoma; Hemorrhage; Humans; Image Enhancement; Iodine; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Radiographic Image Enhancement; Retrospective Studies; Thalamic Diseases; Tomography, X-Ray Computed | 1994 |
MR assessment of radiation-induced blood-brain barrier permeability changes in rat glioma model.
Topics: Animals; Astrocytoma; Blood-Brain Barrier; Brain; Brain Neoplasms; Capillary Permeability; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Image Enhancement; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Permeability; Radiotherapy Dosage; Radiotherapy, High-Energy; Rats; Rats, Inbred F344; Tissue Distribution; Tumor Cells, Cultured | 1994 |
Gadolinium enhancement of the leptomeninges caused by hydrocephalus: a potential mimic of leptomeningeal metastasis.
Topics: Adult; Arachnoid; Astrocytoma; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combinations; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Hydrocephalus; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Meningeal Neoplasms; Organometallic Compounds; Pentetic Acid; Pia Mater | 1994 |
Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
Topics: Aged; Aged, 80 and over; Brain Diseases; Brain Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Neoplasms, Unknown Primary; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed; Vasculitis | 1993 |
MRI of the brain stem using fluid attenuated inversion recivery pulse sequences.
Topics: Adult; Brain Diseases; Brain Neoplasms; Brain Stem; Cerebral Infarction; Cerebrospinal Fluid Shunts; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Hydrocephalus; Lung Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Multiple Sclerosis; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Sarcoidosis | 1993 |
Neuroimaging of juvenile pilocytic astrocytomas: an enigma.
Topics: Adolescent; Adult; Age Factors; Astrocytoma; Brain Neoplasms; Contrast Media; Deoxyglucose; Drug Combinations; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Glucose; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1993 |
Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging.
Topics: Adolescent; Adult; Aged; Astrocytoma; Blood Volume; Brain Neoplasms; Cerebellar Neoplasms; Child; Contrast Media; Drug Combinations; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Glioma; Hemangiosarcoma; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Brain; Brain Diseases; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination.
Topics: Adult; Brain; Brain Neoplasms; Cerebellar Neoplasms; Contrast Media; Drug Combinations; Electroencephalography; Epilepsy, Complex Partial; Gadolinium; Gadolinium DTPA; Glioma; Hemangioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Meningeal Neoplasms; Meningioma; Neurologic Examination; Organometallic Compounds; Pentetic Acid; Prospective Studies; Temporal Lobe | 1995 |
Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.
Topics: Adolescent; Adult; Astrocytoma; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Radiation Injuries | 1996 |
Influence of gastrin on human astrocytic tumor cell proliferation.
Topics: Amino Acid Sequence; Astrocytoma; Autoradiography; Benzodiazepinones; Brain Neoplasms; Cell Division; Cholecystokinin; Devazepide; Gastrins; Hormone Antagonists; Humans; Indoles; Meglumine; Molecular Sequence Data; Peptide Fragments; Phenylurea Compounds; Receptors, Cholecystokinin; Sincalide; Thymidine; Tritium; Tumor Cells, Cultured | 1996 |
MRI findings in children with neurofibromatosis type 1: a prospective study.
Topics: Brain; Brain Neoplasms; Child; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Neurofibromatosis 1; Organometallic Compounds; Pentetic Acid; Prospective Studies | 1996 |
Magnetization transfer or spin-lock? An investigation of off-resonance saturation pulse imaging with varying frequency offsets.
Topics: Adult; Agar; Brain; Brain Diseases; Brain Neoplasms; Cerebrovascular Disorders; Chlorides; Contrast Media; Corn Oil; Drug Combinations; Electron Spin Resonance Spectroscopy; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Macromolecular Substances; Magnetic Resonance Imaging; Male; Manganese Compounds; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Phantoms, Imaging; Water | 1996 |
Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
Topics: Adult; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Contrast Media; Drug Combinations; Echo-Planar Imaging; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Injections, Intravenous; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Pentetic Acid; Tomography, Emission-Computed | 1996 |
Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
Topics: Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid | 1996 |
Magnetic resonance imaging of normal meningeal enhancement at 1.5 T.
Topics: Adolescent; Adult; Aged; Brain; Brain Diseases; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Meninges; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Reference Values | 1996 |
Reverse enhancement of hemorrhagic brain lesions on postcontrast MR: detection with digital image subtraction.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Cerebral Hemorrhage; Child; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Methemoglobin; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Software; Subtraction Technique | 1996 |
Normal contrast enhancement of extraocular muscles: fat-suppressed MR findings.
Topics: Adipose Tissue; Adult; Aged; Brain Neoplasms; Cerebral Infarction; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Oculomotor Muscles; Orbit; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Reference Values | 1997 |
Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging.
Topics: Animals; Blood Proteins; Blood-Brain Barrier; Brain; Brain Neoplasms; Cattle; Contrast Media; Disease Models, Animal; Gadolinium DTPA; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley | 1997 |
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea: an experimental study on human glioblastoma cell lines.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Survival; Drug Interactions; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Glioblastoma; Humans; Lithium Compounds; Meglumine; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured | 1999 |
Feasibility of synchrotron radiation computed tomography on rats bearing glioma after iodine or gadolinium injection. Jeune Equipe RSRM-UJF.
Topics: Animals; Brain Neoplasms; Contrast Media; Feasibility Studies; Female; Gadolinium; Glioma; Ioxaglic Acid; Meglumine; Organometallic Compounds; Rats; Rats, Wistar; Synchrotrons; Tomography, X-Ray Computed; Tumor Cells, Cultured | 2000 |
Use of half-dose gadolinium-enhanced MRI and magnetization transfer saturation in brain tumors.
Topics: Adult; Aged; Brain; Brain Edema; Brain Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Meningeal Neoplasms; Meningioma; Middle Aged; Organometallic Compounds; Sensitivity and Specificity | 2001 |
Comparison of gadobenate dimeglumine and gadopentetate dimeglumine: a study of MR imaging and inductively coupled plasma atomic emission spectroscopy in rat brain tumors.
Topics: Animals; Brain; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Metabolic Clearance Rate; Organometallic Compounds; Rats; Rats, Inbred F344; Spectrophotometry, Atomic | 2002 |
Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Ischemia; Brain Neoplasms; Cerebrovascular Disorders; Contrast Media; Drug Combinations; Encephalitis; Female; Fourier Analysis; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1992 |
[Contrast medium assisted nuclear magnetic resonance tomography. Signal intensity of gliomatous tumors].
Topics: Astrocytoma; Brain; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Meglumine; Neoplasm Staging; Oligodendroglioma; Organometallic Compounds; Pentetic Acid; Sorbitol | 1990 |
Epilepsy in patients with brain metastases triggered by intravenous contrast medium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Epilepsies, Partial; Female; Humans; Infusions, Intravenous; Ioxaglic Acid; Male; Meglumine; Middle Aged; Sorbitol; Tomography, X-Ray Computed | 1989 |
[Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
Topics: Brain Diseases; Brain Neoplasms; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid; Sorbitol | 1988 |